<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26670310</article-id>
      <article-id pub-id-type="pmc">4681144</article-id>
      <article-id pub-id-type="publisher-id">448</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-015-0448-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jeon</surname>
            <given-names>You La</given-names>
          </name>
          <address>
            <email>jyl2658@hanmail.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Woo In</given-names>
          </name>
          <address>
            <phone>+82-2-440-7190</phone>
            <email>wileemd@khu.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Yujin</given-names>
          </name>
          <address>
            <email>eugenius1005@naver.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>So Young</given-names>
          </name>
          <address>
            <email>sykangmd@hanmail.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Myeong Hee</given-names>
          </name>
          <address>
            <email>meikim96@hanmail.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Sung-Jig</given-names>
          </name>
          <address>
            <email>sungjig@khnmc.or.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Sang Ho</given-names>
          </name>
          <address>
            <email>ishnephro@khnmc.or.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Laboratory Medicine, School of Medicine, Kyung Hee University and Kyung Hee University Hospital at Gangdong, 892, Dongnam-ro, Gangdong-gu, Seoul, 134-727 Republic of Korea </aff>
        <aff id="Aff2"><label/>Department of Pathology, School of Medicine, Kyung Hee University and Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea </aff>
        <aff id="Aff3"><label/>Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyung Hee University and Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>213</elocation-id>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Jeon et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Crystalloid podocytopathy with focal segmental glomerulosclerosis in plasma cell myeloma (PCM) is rare.</p>
        </sec>
        <sec>
          <title>Case Presentation</title>
          <p>We present a case of crystalline deposition in the bone marrow (BM) and various renal cells with only proteinuria as a symptom. As workup for proteinuria, a renal biopsy sample was obtained. EM showed multiple crystalline depositions in renal tubular cells and podocytes. Focal segmental glomerulosclerosis with crystalloid podocytopathy was diagnosed. Because monoclonal gammopathy was detected in the serum and urine, a BM study was also performed. Plasma cells with needle-shaped inclusion bodies were observed. The crystalline deposits in the plasma cells and podocytes were positive for Masson&#x2019;s trichrome and kappa light-chain staining. These findings indicated that the crystalline deposits originated from paraprotein. The case showed a rare process of focal segmental glomerulosclerosis via crystalline deposition in podocytes in plasma cell myeloma.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Crystalloid podocytopathy is a likely cause of renal damage such as FSGS in PCM, although it is an uncommon mechanism for myeloma kidney.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Plasma cell myeloma</kwd>
        <kwd>Crystalline deposition</kwd>
        <kwd>Focal and segmental glomerular sclerosis</kwd>
        <kwd>Podocytopathy</kwd>
        <kwd>Tubulopathy</kwd>
        <kwd>Bone marrow</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Monoclonal proteins may take various shapes and forms, such as immunoglobulin (Ig) aggregates, amyloid substances, or even crystalline deposits. In particular, in the rare cases, crystalline deposition can be found in plasma cell myeloma (PCM) as initial presentation of the disease or as a complication in the bone marrow (BM), kidney, or other organs [<xref ref-type="bibr" rid="CR1">1</xref>]. Occasionally, intracellular crystalline deposition has been found in myeloma cells and histiocytes among BM hematopoietic cells [<xref ref-type="bibr" rid="CR2">2</xref>]. The kidneys are more rarely affected with macrophages, glomerular cells, or proximal tubular cells [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Furthermore, reports of cases involving crystalline deposition in podocytes (or glomerular visceral epithelial cells) are extremely rare [<xref ref-type="bibr" rid="CR5">5</xref>]. Here, we report a rare case of focal segmental glomerulosclerosis (FSGS) wherein multiple crystalline inclusions were seen in BM plasma cells and tubular epithelial cells and podocytes in the kidney in a patient with PCM.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 52-year-old woman was referred to a nephrologist for work-up of proteinuria and slightly increased serum creatinine levels found during a routine health examination. The patient had been aware of her proteinuria for 2&#xA0;years. However, she had not undergone further evaluation or treatment. The patient had no other relevant medical history.</p>
      <p>The laboratory results of complete blood count and blood chemistry assay were represented in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. Urinalysis revealed 1+ protein with normal pH, and the results were negative for glucose. Random urine chemistry showed a state of glomerular proteinuria as the results revealed creatinine level of 1847.56&#xA0;&#x3BC;mol/L (20.9&#xA0;mg/dL), microalbumin level of 0.04869&#xA0;g/dL (486.9&#xA0;mg/L), and an albumin/creatinine ratio of 2329.7&#xA0;mg/g. The protein level in the 24-h urine sample was elevated to 2.62&#xA0;g. The patient was then found to have a monoclonal protein concentration of 5.2&#xA0;g/L in serum and 0.01&#xA0;g/L in urine. The serum and urine monoclonal protein fractions were found to represent IgG and kappa in immune fixation electrophoresis. The free kappa and lambda light-chain levels in the serum were 571.6&#xA0;mg/L and 23.3&#xA0;mg/L, respectively, and the serum free light-chain ratio was 24.53 (0.26&#x2009;&#x2212;&#x2009;1.65). There was no evidence suggesting hepatitis B or C virus or human immunodeficiency virus infection on serologic tests.<table-wrap id="Tab1"><label>Table 1</label><caption><p>The laboratory results of complete blood count and blood chemistry</p></caption><table frame="hsides" rules="groups"><thead><tr><th>The test</th><th>Results</th><th>Reference range</th></tr></thead><tbody><tr><td colspan="3">Complete blood count</td></tr><tr><td>&#x2003;WBC count</td><td>4.2&#x2009;&#xD7;&#x2009;10<sup>9</sup> /L</td><td>4.0 - 10.0</td></tr><tr><td>&#x2003;Hemoglobin</td><td>111&#xA0;g/L</td><td>120 - 160</td></tr><tr><td>&#x2003;Platelet count</td><td>180&#x2009;&#xD7;&#x2009;10<sup>9</sup> /L</td><td>350 - 350</td></tr><tr><td colspan="3">Blood chemistry</td></tr><tr><td>&#x2003;Protein</td><td>63&#xA0;g/L</td><td>66 - 83</td></tr><tr><td>&#x2003;Albumin</td><td>33&#xA0;g/L</td><td>35 - 52</td></tr><tr><td>&#x2003;Creatinine</td><td>115.8&#xA0;&#x3BC;mol/L</td><td>44.2 - 79.6</td></tr><tr><td>&#x2003;Calcium</td><td>2.2&#xA0;mmol/L</td><td>2.2 - 2.7</td></tr><tr><td>&#x2003;Phosphorus</td><td>1.1&#xA0;mmol/L</td><td>0.8 - 1.5</td></tr><tr><td>&#x2003;Sodium</td><td>136&#xA0;mmol/L</td><td>136 - 146</td></tr><tr><td>&#x2003;Potassium</td><td>3.8&#xA0;mmol/L</td><td>3.5 - 5.1</td></tr><tr><td>&#x2003;Chloride</td><td>108&#xA0;mmol/L</td><td>101 - 109</td></tr><tr><td>&#x2003;Uric acid</td><td>208.2&#xA0;&#x3BC;mol/L</td><td>154.7 - 356.9</td></tr><tr><td>&#x2003;BUN</td><td>5.4&#xA0;mmol/L</td><td>2.86 - 7.14</td></tr><tr><td>&#x2003;Ig G</td><td>12.2&#xA0;g/L</td><td>0.7 - 1.6</td></tr><tr><td>&#x2003;Ig A</td><td>870&#xA0;mg/L</td><td>700 - 4000</td></tr><tr><td>&#x2003;IgM</td><td>640&#xA0;mg/L</td><td>400 &#x2013; 2300</td></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>WBC</italic> white blood cell, <italic>BUN</italic> blood urea nitrogen, <italic>Ig</italic> immunoglobulin</p></table-wrap-foot></table-wrap></p>
      <p>An ultrasound-guided kidney biopsy was performed; the final pathologic diagnosis was FSGS. Among 16 glomeruli, seven showed global sclerosis and two showed segmental glomerulosclerosis (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). Mild tubular atrophy, mild interstitial fibrosis, and focal tubular necrosis were observed. Interestingly, proximal tubular epithelial cells contained some crystalline structures (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). Congo red staining also produced negative results. Interstitial inflammation with mild infiltration of lymphocytes was noted. Immunofluorescence microscopy showed a linear pattern with trace intensity for IgG and a granular pattern for complement component C3 (++), C1q (+), and fibrinogen (trace) in the glomerulus (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). However, there was no significant positive staining for IgA, IgM, or C4. On performing immunofluorescent staining, the mesangium, tubules, interstitium, and vessels were negative for staining. However, many of the tubular cells showed stronger positivity for the kappa light chain than for the lambda light chain on immunohistochemical staining.<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> Some glomeruli show segmental or global glomerulosclerosis (periodic acid&#x2013;Schiff stain, &#xD7;400 magnification). <bold>b</bold> Fine needle-shaped crystalline structures in proximal tubular epithelial cytoplasm, which were negative for periodic acid-Schiff staining (Masson&#x2019;s trichrome stain, &#xD7;400). Crystalline deposition was observed in podocytes (<bold>c</bold>) and proximal tubular epithelial cells with many large and abnormal lysosomes (<bold>d</bold>). The morphology of the crystalline structures was diverse and ranged from a needle shape to a rhomboid shape (electron micrograph, original magnification: <bold>c</bold>, &#xD7;5,000; <bold>d</bold>, &#xD7;6,000)</p></caption><graphic xlink:href="13000_2015_448_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Immunofluorescence microscopy of the glomerulus. <bold>a</bold> A linear pattern for IgG (trace) (x200 magnification). <bold>b</bold>, <bold>c</bold>, and <bold>d</bold>, A granular pattern for complement component C3 (++), C1q (+), and for fibrinogen (trace) (<bold>b</bold>, x200; <bold>c</bold>, x100; <bold>d</bold>, x100 magnification)</p></caption><graphic xlink:href="13000_2015_448_Fig2_HTML" id="MO2"/></fig></p>
      <p>Electron microscopic examination revealed diffuse effacement of foot processes and electron-dense deposits, with some crystalline structures in the cytoplasm of visceral glomerular epithelial cells. Furthermore, similar electron-dense crystalline deposits found in podocytes were observed throughout the cytoplasm of proximal tubular cells (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref> and <xref rid="Fig1" ref-type="fig">d</xref>). These showed diverse morphology with a needle shape or a rhomboid shape and variable size ranging from 0.2&#x2009;&#xD7;&#x2009;1 to 0.5&#x2009;&#xD7;&#x2009;2.8&#xA0;&#x3BC;m<sup>2</sup>. However, no pathologic abnormalities were noted within the glomerular basement membrane, mesangium, or glomerular endothelium.</p>
      <p>A BM examination was performed to investigate for the presence of plasma-cell neoplasms. The BM aspirate smears were stained with Wright&#x2019;s stain. The plasma cells with fine needle-shaped intracellular crystalline depositions were found to have increased in number, representing up to 10.4&#xA0;% of the total nucleated cells counted (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref>). Typical plasma cells were rarely observed. All of the cells with intracellular cytoplasmic crystalline inclusions were negative for &#x3B1;-naphthyl acetate esterase (ANBE) staining, suggesting that macrophages such as histiocytes were not involved. The paraffin-embedded BM biopsy and clot sections were stained with hematoxylin and eosin. The cellularity of the BM was 30&#x2013;40&#xA0;%, that is, she had normocellular marrow for her age. Cells with red-colored cytoplasmic inclusions and eccentric mononucleosis, which seemed to be malignant plasma cells, were frequently seen in the clot sections (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>). Immunohistochemical staining was performed on the BM clot sections with antibodies against CD138, kappa light-chain, and lambda light-chain. Plasma cells stained with CD138 were seen in these sections more frequently than in the aspiration smear. The plasma cells showed strongly positive staining for kappa light-chains (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref>). However, a few of the plasma cells were positive for lambda light-chain staining. Masson&#x2019;s trichrome staining was performed on clot sections to evaluate the characteristic features of the crystalline deposits. The plasma cells had deep-red-colored cytoplasmic inclusions with fine needle-shaped structures (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3d</xref>). These cells were negative in periodic acid-Schiff staining.<fig id="Fig3"><label>Fig. 3</label><caption><p>
<bold>a</bold> Plasma cells with fine needle-shaped intracellular crystalline depositions were frequently seen in the bone marrow (Wright&#x2019;s stain, &#xD7;1,000 magnification). <bold>b</bold> The red-colored cytoplasmic inclusions and eccentric mononucleosis were frequently observed in the clot sections (hematoxylin and eosin staining, (<bold>b)</bold>&#x2009;&#xD7;&#x2009;400 magnification) (inset, &#xD7;1,000 magnification). <bold>c</bold> The plasma cells were stained strongly for the kappa light-chain. Some fine needle-shaped crystalline depositions were also observed in the cells (&#xD7;400 magnification) (inset, &#xD7;1,000 magnification). <bold>d</bold> The deep-red-colored cytoplasmic inclusions with fine needle-shaped structures considered to be crystalline deposits (Masson's trichrome stain, &#xD7;1000)</p></caption><graphic xlink:href="13000_2015_448_Fig3_HTML" id="MO3"/></fig></p>
      <p>The complex karyotype of 44,X,-X,-6,-21,+mar[2]/46,XX[53] was determined by conventional karyotyping using the BM specimen. The fluorescence <italic>in situ</italic> hybridization studies for detecting cytogenetic abnormalities such as <italic>TP53</italic> deletion, 13q14 (<italic>RB1</italic>) deletion, 1q trisomy, and rearrangement of <italic>IgH/MAF</italic> - t(14;16), <italic>IgH/FGFR3</italic> - t(4;14), <italic>IGH/CCND1</italic> - t(11;14) were found to be negative.</p>
    </sec>
    <sec id="Sec3">
      <title>Discussion</title>
      <p>A portion of patients with renal disease are diagnosed with PCM [<xref ref-type="bibr" rid="CR6">6</xref>]. Approximately 60&#xA0;% of PCM patients have renal failure, and proteinuria can be found in 90&#xA0;% of these patients [<xref ref-type="bibr" rid="CR7">7</xref>]. Most of the cases of PCM with renal involvement show myeloma cast nephropathy (light-chain cast nephropathy) and low-molecular-weight proteinuria [<xref ref-type="bibr" rid="CR8">8</xref>]. Amyloidosis and monoclonal Ig deposition disease are seen less commonly. Moreover, crystalline deposition is an even more rare presentation. In previous reports, the organs shown to be involved in PCM were the kidneys, skin, liver, lung, spleen, and stomach and various other tissues such as those of the cornea. [<xref ref-type="bibr" rid="CR9">9</xref>-<xref ref-type="bibr" rid="CR11">11</xref>]</p>
      <p>Except tubular luminal involvement (myeloma cast nephropathy), the main pathologic feature accompanying crystalline deposition in the kidney is light-chain-associated Fanconi syndrome [<xref ref-type="bibr" rid="CR12">12</xref>]. Light chains secreted by monoclonal plasma cells are reabsorbed by proximal tubular epithelial cells, and on rare occasions, intracellular crystals are formed during this process. These crystals impair tubular function and disrupt overall reabsorption capabilities causing various aggressive symptoms such as glycosuria, aminoaciduria, hyperuricosuria, hyperphosphaturia, and hypercalciuria [<xref ref-type="bibr" rid="CR13">13</xref>]. In most of these patients, kappa light-chains are typically involved as components of their monoclonal proteins [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The variability subtype Vk1 has the property of resistance to proteolysis by the lysosomal enzyme cathepsin B in tubular epithelial cells [<xref ref-type="bibr" rid="CR15">15</xref>]. This characteristic of Vk1 is due to germline mutations of <italic>O2/O12</italic> or <italic>O8/O18</italic> [<xref ref-type="bibr" rid="CR14">14</xref>]. Among these genes, a major mutation of <italic>O2/O12</italic> induces a nonpolar or hydrophobic residue at position 30, which represents complementarity-determining region L1 of light chains and forms a portion of the Ig antigen-binding site [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Interestingly, our patient showed crystalline deposition in podocytes as well as proximal tubular epithelial cells. Crystalloid podocytopathy is rare, but may occur due to its similar endocytic function of the proximal tubular epithelial cells [<xref ref-type="bibr" rid="CR16">16</xref>]. Recent studies have reported that in healthy rats, an amount of albumin passes through the glomerular filtration barrier [<xref ref-type="bibr" rid="CR17">17</xref>]. Podocytes take up albumin and other plasma proteins and process these through degradation or transcytosis [<xref ref-type="bibr" rid="CR16">16</xref>]. The degradation of albumin occurs in the lysosomes of podocytes [<xref ref-type="bibr" rid="CR18">18</xref>]. Monoclonal proteins are also considered to be processed in the same manner. If any of these monoclonal proteins are resistant to proteolysis, this may result in crystal formation. Furthermore, the membranous endocytic receptors of proximal tubular epithelial cells, such as megalin, cubilin, and CIC-5, have been found in human podocytes [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p>Podocytopathy caused by crystalline deposits is a very rare phenomenon and only ten cases have been reported in the literature so far [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR9">9</xref>-<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR20">20</xref>-<xref ref-type="bibr" rid="CR24">24</xref>]. The reported cases of crystalloid podocytopathy always involved additional crystalline deposition in other cells in the kidney. Accompanying foot process effacement was common (eight cases out of 11, including the present case), and sclerotic glomeruli implying FSGS was also a common finding (eight cases out of 11). FSGS was considered to occur by crystalloid podocytopathy and paraproteinemia itself in our patient because no other causative factors such as viral infection, drug therapy, or toxins were involved [<xref ref-type="bibr" rid="CR25">25</xref>]. Proteinuria of various degrees was noted, and over 24&#xA0;h, the urine protein levels ranged from 0.31&#xA0;mg to 14.4&#xA0;g. In this case, the patient presented with glomerular proteinuria, which could be attributed to the crystalline deposition of podocytes.</p>
      <p>Although the majority of the cases of podocytopathy caused by crystalline deposits had concurrent tubulopathy (six cases out of 11 had obvious signs of tubulopathy, three cases had no definite description of proximal tubule injury, one case had distal tubulopathy, and one case had no tubulopathy), there was only one case of Fanconi syndrome. Our patient showed only proteinuria with renal insufficiency. It is possible for distributed accumulation of pathologic light-chains in both the glomeruli and tubules to have caused these findings. Such conditions may induce milder impairment of proximal tubular function than sole presentation of proximal tubulopathy.</p>
      <p>A morphologically distinguishable feature of this case was the crystalline deposits in BM plasma cells. Among previous cases with crystalloid podocytopathy, only four were described with such findings. Plasma cells may possess crystallized cytoplasmic Ig in their abundant endoplasmic reticulum with various shapes of crystal [<xref ref-type="bibr" rid="CR2">2</xref>]. The presence of crystalline deposits does not definitively imply the existence of malignant plasma cell dyscrasia because they can also be observed in reactive plasma cells [<xref ref-type="bibr" rid="CR26">26</xref>]. In fact, the presence of these deposits could be a favorable prognostic finding, along with slow and prolonged disease course, due to the accompaniment of decreased secretion of monoclonal proteins [<xref ref-type="bibr" rid="CR27">27</xref>]. However, the proportion of patients who had plasma cells with cytoplasmic crystalline deposition in crystalloid podocytopathy (four cases out of 11) or tubulopathy (13 cases out of 57) in a previous study was not low, and the exact duration of these diseases is mostly unknown [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
    </sec>
    <sec id="Sec4">
      <title>Conclusion</title>
      <p>Our patient&#x2019;s sole problem was a proteinuria, besides glomerular proteinuria. Multi-directional clinical, laboratory, and pathologic diagnostic methods contribute to making an accurate diagnosis and understanding pathophysiology. Crystalloid podocytopathy is a likely cause of renal damage such as FSGS in PCM, although it is an uncommon mechanism for myeloma kidney. Furthermore, the present case highlights an instance of morphologically and histologically rare findings of crystalline podocytopathy and tubulopathy in the kidney and crystalline deposition in plasma cells in the BM.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BM</term>
          <def>
            <p>Bone marrow</p>
          </def>
        </def-item>
        <def-item>
          <term>FSGS</term>
          <def>
            <p>Focal segmental glomerulosclerosis</p>
          </def>
        </def-item>
        <def-item>
          <term>Ig</term>
          <def>
            <p>Immunoglobulin</p>
          </def>
        </def-item>
        <def-item>
          <term>PCM</term>
          <def>
            <p>Plasma cell myeloma</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>YLJ drafted the report, contributed to the concept. WIL contributed to the concept and design and approved the final version of the manuscript. YC collected data of the patient. SYK and MHK made relevant corrections. S-JL contributed to reading of renal pathology. SHL contributed to the concept and cared for the patient. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>None.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molina-Garrido</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Guill&#xE9;n-Ponce</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mora</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guirado-Risue&#xF1;o</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deposition-associated diseases related with a monoclonal compound</article-title>
          <source>Clin Transl Oncol.</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>777</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1007/s12094-007-0139-8</pub-id>
          <pub-id pub-id-type="pmid">18158981</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press; 2008.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lebeau</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zeindl-Eberhart</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller-H&#xF6;cker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jungblut</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Emmerich</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature</article-title>
          <source>Blood.</source>
          <year>2002</year>
          <volume>100</volume>
          <fpage>1817</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">12176905</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomioka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ueki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Isoda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kuroiwa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Widespread crystalline inclusions affecting podocytes, tubular cells and interstitial histiocytes in the myeloma kidney</article-title>
          <source>Clin Nephrol.</source>
          <year>2004</year>
          <volume>62</volume>
          <fpage>229</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.5414/CNP62229</pub-id>
          <pub-id pub-id-type="pmid">15481856</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akilesh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alem</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nicosia</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Combined crystalline podocytopathy and tubulopathy associated with multiple myeloma</article-title>
          <source>Hum Pathol.</source>
          <year>2014</year>
          <volume>45</volume>
          <fpage>875</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2013.10.007</pub-id>
          <pub-id pub-id-type="pmid">24439928</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korbet</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Multiple myeloma</article-title>
          <source>J Am Soc Nephrol.</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>2533</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2006020139</pub-id>
          <pub-id pub-id-type="pmid">16885408</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kyle</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Multiple myeloma: review of 869 cases</article-title>
          <source>Mayo Clin Proc.</source>
          <year>1975</year>
          <volume>50</volume>
          <fpage>29</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">1110582</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Markowitz</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Dysproteinemia and the kidney</article-title>
          <source>Adv Anat Pathol.</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>49</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1097/00125480-200401000-00005</pub-id>
          <pub-id pub-id-type="pmid">14676640</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Faull</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Swift</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bannister</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Crystalloid deposits in the kidney</article-title>
          <source>Nephrology (Carlton)</source>
          <year>2005</year>
          <volume>10</volume>
          <fpage>81</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1797.2005.00290.x</pub-id>
          <pub-id pub-id-type="pmid">15705186</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papla</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sp&#xF3;lnik</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rzenno</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zdu&#x144;czyk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rudzki</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Oko&#x144;</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain</article-title>
          <source>Virchows Arch.</source>
          <year>2004</year>
          <volume>445</volume>
          <fpage>83</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15278450</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hishida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Shirasawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagase</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma</article-title>
          <source>Arch Pathol Lab Med.</source>
          <year>1991</year>
          <volume>115</volume>
          <fpage>351</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">2012495</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herlitz</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>D'Agati</surname>
              <given-names>VD</given-names>
            </name>
            <name>
              <surname>Markowitz</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Crystalline nephropathies</article-title>
          <source>Arch Pathol Lab Med.</source>
          <year>2012</year>
          <volume>136</volume>
          <fpage>713</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.5858/arpa.2011-0565-RA</pub-id>
          <pub-id pub-id-type="pmid">22742545</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stomp&#xF3;r</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Perkowska-Ptasi&#x144;ska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wojciechowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zaj&#x105;c</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chmielewska-Badzi&#x105;g</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paw&#x142;owska</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Unusual manifestation of crystalline light chain tubulopathy in patient with multiple myeloma: case report and review of the literature</article-title>
          <source>Ren Fail.</source>
          <year>2014</year>
          <volume>36</volume>
          <fpage>795</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.3109/0886022X.2014.884446</pub-id>
          <pub-id pub-id-type="pmid">24512271</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Messiaen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Deret</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mougenot</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bridoux</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dequiedt</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dion</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients</article-title>
          <source>Medicine (Baltimore)</source>
          <year>2000</year>
          <volume>79</volume>
          <fpage>135</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1097/00005792-200005000-00002</pub-id>
          <pub-id pub-id-type="pmid">10844934</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leboulleux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lelongt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mougenot</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Touchard</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Makdassi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rocca</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies</article-title>
          <source>Kidney Int.</source>
          <year>1995</year>
          <volume>48</volume>
          <fpage>72</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.1995.269</pub-id>
          <pub-id pub-id-type="pmid">7564094</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eyre</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ioannou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grubb</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Saleem</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mathieson</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Brunskill</surname>
              <given-names>NJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Statin-sensitive endocytosis of albumin by glomerular podocytes</article-title>
          <source>Am J Physiol Renal Physiol.</source>
          <year>2007</year>
          <volume>292</volume>
          <fpage>F674</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1152/ajprenal.00272.2006</pub-id>
          <pub-id pub-id-type="pmid">17032937</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandoval</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Campos-Bilderback</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiple factors influence glomerular albumin permeability in rats</article-title>
          <source>J Am Soc Nephrol.</source>
          <year>2012</year>
          <volume>23</volume>
          <fpage>447</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2011070666</pub-id>
          <pub-id pub-id-type="pmid">22223875</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carson</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Okamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wakashin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>McFann</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dobrinskikh</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kopp</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Podocytes degrade endocytosed albumin primarily in lysosomes</article-title>
          <source>PLoS One.</source>
          <year>2014</year>
          <volume>9</volume>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0099771</pub-id>
          <pub-id pub-id-type="pmid">24924335</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kuwahara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells</article-title>
          <source>Membranes (Basel)</source>
          <year>2014</year>
          <volume>4</volume>
          <fpage>333</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.3390/membranes4030333</pub-id>
          <pub-id pub-id-type="pmid">25019425</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nasr</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Preddie</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Markowitz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Appel</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>D'Agati</surname>
              <given-names>VD</given-names>
            </name>
          </person-group>
          <article-title>Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes</article-title>
          <source>Kidney Int.</source>
          <year>2006</year>
          <volume>69</volume>
          <fpage>616</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.ki.5000144</pub-id>
          <pub-id pub-id-type="pmid">16514437</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowalewska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tomford</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Alpers</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Crystals in podocytes: an unusual manifestation of systemic disease</article-title>
          <source>Am J Kidney Dis.</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>605</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1016/S0272-6386(03)00794-7</pub-id>
          <pub-id pub-id-type="pmid">12955694</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuyama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Joh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Aizawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kitajima</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis</article-title>
          <source>Am J Kidney Dis.</source>
          <year>1994</year>
          <volume>23</volume>
          <fpage>859</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/S0272-6386(12)80141-7</pub-id>
          <pub-id pub-id-type="pmid">8203369</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carstens</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Crystalline glomerular inclusions in multiple myeloma</article-title>
          <source>Am J Kidney Dis.</source>
          <year>1989</year>
          <volume>14</volume>
          <fpage>56</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1016/S0272-6386(89)80095-2</pub-id>
          <pub-id pub-id-type="pmid">2545097</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elliott</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Cortese</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moreno-Aspitia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Plasma cell dyscrasia causing light chain tubulopathy without Fanconi syndrome</article-title>
          <source>Am J Kidney Dis.</source>
          <year>2010</year>
          <volume>55</volume>
          <fpage>1136</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2009.08.010</pub-id>
          <pub-id pub-id-type="pmid">19850387</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dingli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Plevak</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Grande</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Focal and segmental glomerulosclerosis and plasma cell proliferative disorders</article-title>
          <source>Am J Kidney Dis.</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>278</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2005.05.004</pub-id>
          <pub-id pub-id-type="pmid">16112046</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Spagnolo</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>Crystalline plasma cell inclusions in helicobacter-associated gastritis</article-title>
          <source>J Clin Pathol.</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>851</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.2005.033233</pub-id>
          <pub-id pub-id-type="pmid">16537672</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>LD</given-names>
            </name>
          </person-group>
          <article-title>Crystalline inclusions in multiple myeloma</article-title>
          <source>JAMA.</source>
          <year>1985</year>
          <volume>254</volume>
          <fpage>1985</fpage>
          <pub-id pub-id-type="doi">10.1001/jama.1985.03360140143043</pub-id>
          <pub-id pub-id-type="pmid">2995693</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
